According to a newly published market research report by 24LifeSciences, global Bruton's Tyrosine Kinase (BTK) inhibitors market was valued at USD 6,941 million in 2024 and is projected to reach USD 9,622 million by 2031, growing at a compound annual growth rate (CAGR) of 4.9% during the forecast period. BTK inhibitors are small molecule therapeutics that selectively inhibit the Bruton's...